Maintenance of clinical remission in ANCA-associated vasculitis.
A fundamental change in management of antineutrophil cytoplasmic antibody-associated vasculitis in the past 10 years is the early focussed use of aggressive immunosuppression, using regimens comprised of widely available medications. Using a clinical framework to quantify morbidity, we can induce re...
| Autor principal: | |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
2013
|